Which Treatment Suits Your Weight Management Goals?
Wegovy or Mounjaro Online: Understanding Your UK Buying Options
When deciding between Wegovy or Mounjaro, purchasing online through a registered UK pharmacy offers distinct advantages over traditional clinic visits. EverydayMeds provides both treatments through our streamlined digital platform, eliminating lengthy waiting times and appointment scheduling constraints. Our online clinical assessment takes just 3 minutes and covers the same comprehensive medical history review that you'd receive in person. The key difference lies in convenience: you can complete your assessment at any time, receive prescriber review within 3 working days (or 24 hours with express service), and have your chosen medication delivered via temperature-controlled courier.
Both Wegovy and Mounjaro require identical assessment procedures, so you can compare both options during your consultation. Our prescribers are qualified to recommend either treatment based on your individual medical profile, BMI requirements, and any weight-related comorbidities. This dual-availability approach means you're not limited to whatever treatment a specific clinic might prefer or stock. Instead, you receive genuinely personalised recommendations backed by clinical evidence and regulatory approval from the MHRA.
Pricing Comparison: Wegovy or Mounjaro Cost Breakdown
Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles offer convenience for dose escalation: the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99. New customers use code FIRST40 at checkout, and returning customers apply DOSE25 to access these competitive prices. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment.
Mounjaro follows a different pricing structure, reflecting its newer dual-agonist mechanism and manufacturing costs. Both treatments represent significant investments in your health, and our bundle options provide Reliable Supply continuity without the hassle of monthly reordering. The choice between Wegovy or Mounjaro often comes down to individual response, tolerability, and prescriber recommendation rather than price alone. Our clinical team can discuss both options during your assessment, ensuring you make an informed decision based on medical suitability rather than cost considerations alone.
Clinical Evidence: Wegovy or Mounjaro Effectiveness
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different populations, with STEP 2 showing 9.6% weight reduction in patients with type 2 diabetes, and STEP 5 maintaining clinically studied weight loss at 2 years. The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Mounjaro's clinical programme focused on different endpoints and populations, making direct comparison inappropriate. Both treatments demonstrated significant efficacy in their respective trials when used alongside lifestyle interventions. Your individual response may vary, and sustained results require ongoing commitment to dietary changes and physical activity. Our prescribers review the latest clinical data to help determine which treatment aligns with your medical history and weight management goals.
How Wegovy or Mounjaro Work in Your Body
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone released after eating. It works by slowing gastric emptying, which helps you feel full for longer after meals, and acts on brain appetite centres to reduce food cravings. This dual mechanism supports portion control and can help break patterns of emotional or habitual overeating. Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors, potentially offering enhanced metabolic effects through this dual-pathway approach. Both treatments require weekly injections using pre-filled pens and work best when combined with sustainable lifestyle changes including a reduced-calorie diet and increased physical activity.
Streamlined Ordering: Wegovy or Mounjaro Delivery Process
Our ordering process for either Wegovy or Mounjaro begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any contraindications. Our qualified prescribers review your submission within 3 working days (24 hours with express service), ensuring safe and appropriate prescribing in line with MHRA guidelines. Once approved, your prescription-only medicine is dispatched via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. You'll receive tracking information and delivery confirmation, with temperature monitoring logs available on request. Our customer support team remains available throughout your treatment journey, whether you're using Wegovy or Mounjaro, providing ongoing guidance and addressing any questions that arise.
Storage and Practical Considerations: Wegovy or Mounjaro Handling
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, but they differ in room temperature stability once removed from the fridge. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks, offering superior travel convenience compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with irregular schedules. Both treatments use similar injection techniques with pre-filled FlexTouch or equivalent pen devices, administered once weekly on the same day each week. Dose escalation follows prescribed schedules: Wegovy increases every 4 weeks (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg), whilst Mounjaro has its own escalation protocol, and you cannot skip doses or accelerate the schedule without prescriber approval.
UK Regulatory Status: Wegovy or Mounjaro Legal Purchasing
Both Wegovy and Mounjaro hold full MHRA marketing authorisation for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. NICE recommendation TA875 supports Wegovy use with specialist weight management services, whilst Mounjaro has separate NICE guidance reflecting its newer market entry. As prescription-only medicines, both require legitimate UK prescriptions from qualified prescribers, and purchasing from unlicensed sources carries significant health and legal risks. EverydayMeds operates under strict GPhC regulation (#9012878), ensuring every transaction complies with UK pharmaceutical legislation.
The regulatory landscape continues evolving, with both treatments subject to ongoing safety monitoring and potential label updates. Our clinical team stays current with MHRA communications, product information updates, and emerging safety data to ensure patients receive accurate, up-to-date guidance. This regulatory oversight provides assurance that your chosen treatment—whether Wegovy or Mounjaro—meets the highest UK safety and efficacy standards.
Making Your Decision: Expert Support for Wegovy or Mounjaro
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment suits your individual circumstances. Our clinical assessment considers factors including your medical history, previous weight management attempts, current medications, and personal preferences regarding injection frequency and storage requirements. Rather than choosing blindly, you'll receive professional guidance based on clinical evidence and practical considerations. New customers can begin their journey with code FIRST40, whilst returning customers use DOSE25 to access competitive pricing on either treatment. Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment today and discover which option—Wegovy or Mounjaro—best supports your weight management goals. Our GPhC-registered pharmacy ensures safe, legal access to genuine medications with ongoing support throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
